Tryptophan hydroxylase gene associated with paroxetine antidepressant activity

European Neuropsychopharmacology

Volumn 11, Issue 5, 2001, Pages 375-380

  Serretti, Alessandro ^a   Zanardi, Raffaella ^a   Cusin, Cristina ^a   Rossini, David ^a   Lorenzi, Cristina ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant treatment; Mood disorders; Pharmacogenetics; Pindolol

Indexed keywords

PAROXETINE; PINDOLOL; PLACEBO; TRYPTOPHAN HYDROXYLASE;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; GENE ACTIVITY; GENE THERAPY; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DNA; FEMALE; HUMANS; INDIVIDUALITY; MALE; MIDDLE AGED; PAROXETINE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; TRYPTOPHAN HYDROXYLASE;

EID: 0034795789     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00113-4     Document Type: Article

References (57)

1. Suicidal behaviors and the tryptophan hydroxylase gene
2. Scales for assessment of diagnosis and severity of mental disorders
3. Association between the tryptophan hydroxylase gene and manic-depressive illness
4. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
5. Tryptophan hydroxylase polymorphisms in suicide victims
6. Progress and pitfalls: Bipolar molecular linkage studies
7. Complete coding sequence of human tryptophan hydroxylase
8. Genetic association study in psychiatry: Analytical evaluation and a recommendation
9. Lithium-responsive affective disorders: No association with the tyrosine hydroxylase gene
10. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization
11. Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH)
12. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
13. Who's afraid of epistasis?
14. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways
15. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways
16. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder
17. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families
18. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))
19. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset
20. Development of a rating scale for primary depressive illness
21. No coding variant of tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism
22. The 5′ region of the tryptophan hydroxylase gene: Mutation search and association study with alcoholism
23. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: Relationships to monoamine metabolite concentrations in CSF of healthy volunteers
24. Serotonin transporter gene polymorphism and antidepressant response
25. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
26. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor
27. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients
28. Advances in the molecular characterization of tryptophan hydroxylase
29. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism
30. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7
31. A tryptophan hydroxylase gene marker for suicidality and alcoholism
32. Pharmacogenetic response to antidepressant in a multicase family with affective disorder
33. Tryptophan hydroxylase gene polymorphisms are not associated with suicide
34. Antidepressant responses and segregation analyses in affective families
35. TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population
36. Differentiation of two genetically specific types of depression by the response to antidepressant
37. Pharmacogenomics of psychiatric disorders
38. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
39. Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls
40. Linkage strategies for genetically complex traits: I. multilocus models
41. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior
42. L-Tryptophan in neuropsychiatric disorders: A review
43. Depression
44. Mode of inheritance in mood disorders families according to fluvoxamine response
45. Patterns of symptom improvement during antidepressant treatment of delusional depression
46. The search for genetic homogeneity in affective disorders
47. Outcomes on lithium treatment as a tool for genetic studies in affective disorders
48. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
49. Relapse of depression after rapid depletion of tryptophan
50. No association between chromosome-18 markers and lithium-responsive affective disorders
51. Pharmacogenetics and the serotonin system: Initial studies and future directions
52. Genetic association analysis of serotonin system genes in bipolar affective disorder
53. Use of tryptophan in combination with other antidepressant treatments: A review
54. How long should Pindolol be associated with Paroxetine to improve the antidepressant response?
55. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene
56. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression